Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies to Redeem $350M in Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies said after the close of the market Wednesday that it plans to redeem all of the outstanding 2 percent convertible senior notes due 2023.

The firm said that as of June 30, there was $349,544,000 in aggregate principal amount of the notes outstanding. The notes are convertible any time before 5:00 PM Eastern Time on Aug. 5, 2010, at a rate of 29.3094 shares of common stock per $1,000 principal amount of the notes surrendered.

Life Technologies said that it would settle the surrendered notes in cash and stock in accordance with the provisions of the indentures.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.